Niagen Bioscience (NAGE) Operating Margin Growth (5y) (2015 - 2026)
Niagen Bioscience (NAGE) Operating Margin Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Niagen Bioscience | 253.47 Mn | 186.92 Mn | 19.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5,515.00 |
| Dec 31, 2025 | 5,145.00 |
| Sep 30, 2025 | 4,205.00 |
| Jun 30, 2025 | 3,435.00 |
| Mar 31, 2025 | 5,672.00 |
| Dec 31, 2024 | 9,211.00 |
| Sep 30, 2024 | 6,341.00 |
| Jun 30, 2024 | 6,355.00 |
| Mar 31, 2024 | 8,002.00 |
| Dec 31, 2023 | 9,009.00 |
| Sep 30, 2023 | 9,998.00 |
| Jun 30, 2023 | 9,032.00 |
| Mar 31, 2023 | 11,917.00 |
| Dec 31, 2022 | 10,968.00 |
| Sep 30, 2022 | 3,424.00 |
| Jun 30, 2022 | 2,465.00 |
| Mar 31, 2022 | 784.00 |
| Dec 31, 2021 | 1,884.00 |
| Sep 30, 2021 | -2,761.00 |
| Jun 30, 2021 | -3,352.00 |